nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
|
Debie, Yana |
|
|
163 |
C |
p. 177-179 |
artikel |
2 |
Association between alcohol consumption and pancreatic cancer risk differs by glycaemic status: A nationwide cohort study
|
Park, Joo-Hyun |
|
|
163 |
C |
p. 119-127 |
artikel |
3 |
A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases
|
Wada, Yuma |
|
|
163 |
C |
p. 66-76 |
artikel |
4 |
Cetuximab and vemurafenib plus FOLFIRI (5-fluorouracil/leucovorin/irinotecan) for BRAF V600E-mutated advanced colorectal cancer (IMPROVEMENT): An open-label, single-arm, phase II trial
|
Wang, Zhan |
|
|
163 |
C |
p. 152-162 |
artikel |
5 |
Development and validation of a transcriptomics-based gene signature to predict distant metastasis and guide induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
|
Liu, Sai-Lan |
|
|
163 |
C |
p. 26-34 |
artikel |
6 |
Diagnostic and prognostic classification of atypical spitzoid tumours based on histology and genomic aberrations: A prospective cohort study with long-term follow-up
|
Gassenmaier, Maximilian |
|
|
163 |
C |
p. 200-210 |
artikel |
7 |
Differences in treatment and survival of older patients with operable breast cancer between the United Kingdom and the Netherlands – A comparison of two national prospective longitudinal multi-centre cohort studies
|
van der Plas-Krijgsman, Willeke G. |
|
|
163 |
C |
p. 189-199 |
artikel |
8 |
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and ‘MAGIC’ regimens
|
Moore, Jonathan L. |
|
|
163 |
C |
p. 180-188 |
artikel |
9 |
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
|
Papamichael, Demetris |
|
|
163 |
C |
p. 1-15 |
artikel |
10 |
Evolution of low HER2 expression between early and advanced-stage breast cancer
|
Tarantino, Paolo |
|
|
163 |
C |
p. 35-43 |
artikel |
11 |
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials
|
Baldini, Capucine |
|
|
163 |
C |
p. 98-107 |
artikel |
12 |
Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network
|
Battistella, Maxime |
|
|
163 |
C |
p. 211-221 |
artikel |
13 |
Impaired seroconversion after SARS-CoV-2 mRNA vaccines in patients with solid tumours receiving anticancer treatment
|
Amatu, Alessio |
|
|
163 |
C |
p. 16-25 |
artikel |
14 |
Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus
|
Atkinson, Victoria |
|
|
163 |
C |
p. 79-87 |
artikel |
15 |
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment
|
Sculco, Marika |
|
|
163 |
C |
p. 44-54 |
artikel |
16 |
Next-generation sequencing reveals tumour origin in a patient with rare metachronous colonic metastasis from pancreatic cancer
|
Zhu, Jing |
|
|
163 |
C |
p. 77-78 |
artikel |
17 |
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only − the SIOP 93–01 and 2001 protocols
|
Groenendijk, Alissa |
|
|
163 |
C |
p. 88-97 |
artikel |
18 |
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
|
Sonpavde, Guru P. |
|
|
163 |
C |
p. 55-65 |
artikel |
19 |
Progress against non-Hodgkin's lymphoma in children and young adolescents in the Netherlands since 1990: Stable incidence, improved survival and lower mortality
|
Reedijk, Ardine M.J. |
|
|
163 |
C |
p. 140-151 |
artikel |
20 |
Real-world reference scores for EORTC QLQ-C30 and EORTC QLQ-BR23 in early breast cancer patients
|
Karsten, Maria M. |
|
|
163 |
C |
p. 128-139 |
artikel |
21 |
Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
|
Drobni, Zsofia D. |
|
|
163 |
C |
p. 108-118 |
artikel |
22 |
Tumour-agnostic circulating tumour DNA analysis for improved recurrence surveillance after resection of colorectal liver metastases: A prospective cohort study
|
Øgaard, Nadia |
|
|
163 |
C |
p. 163-176 |
artikel |